中草藥治療哮喘的免疫調(diào)節(jié)作用最新研究進展
發(fā)布時間：2019-08-07 10:00
【摘要】：哮喘是由多種免疫細胞參與的慢性呼吸道炎癥疾病,常常導致氣促、胸悶、咳嗽以及反復發(fā)作的喘息等癥狀,往往出現(xiàn)氣流阻塞,影響人體健康。中草藥(CHM)用于治療哮喘已經(jīng)有上千年的歷史,大量研究表明中草藥能有效的調(diào)節(jié)細胞免疫反應減緩哮喘癥狀。該文綜述了近幾年來中草藥對免疫細胞的調(diào)節(jié)作用及相關分子機制的研究,包括炎癥細胞數(shù)量、樹突狀細胞成熟、輔助性T細胞亞型之間的平衡、調(diào)節(jié)性T細胞的誘導及胞內(nèi)信號通路,并展望了未來的研究方向。
[Abstract]:Asthma is a chronic airway inflammation disease, which is involved in many immune cells, which often leads to the symptoms of shortness of breath, chest distress, cough, and wheezing and other symptoms, and the air flow is often blocked and the health of the human body is affected. Chinese herbal medicine (CHM) has been used in the treatment of asthma, and a large number of studies have shown that the Chinese herbal medicine can effectively regulate cellular immune response and slow the symptoms of asthma. The effects of Chinese herbal medicines on immune cells and related molecular mechanisms in recent years have been reviewed, including the number of inflammatory cells, the maturation of dendritic cells, the balance between the helper T-cell subtypes, the induction of regulatory T cells and the intracellular signaling pathway, And the future research direction is also looked forward.
【作者單位】： 新疆生物資源基因工程重點實驗室新疆大學生命科學與技術學院;烏魯木齊市第二十三中學;
【基金】：國家自然科學基金項目(31460241)
【分類號】：R256.12
[Abstract]:Asthma is a chronic airway inflammation disease, which is involved in many immune cells, which often leads to the symptoms of shortness of breath, chest distress, cough, and wheezing and other symptoms, and the air flow is often blocked and the health of the human body is affected. Chinese herbal medicine (CHM) has been used in the treatment of asthma, and a large number of studies have shown that the Chinese herbal medicine can effectively regulate cellular immune response and slow the symptoms of asthma. The effects of Chinese herbal medicines on immune cells and related molecular mechanisms in recent years have been reviewed, including the number of inflammatory cells, the maturation of dendritic cells, the balance between the helper T-cell subtypes, the induction of regulatory T cells and the intracellular signaling pathway, And the future research direction is also looked forward.
【作者單位】： 新疆生物資源基因工程重點實驗室新疆大學生命科學與技術學院;烏魯木齊市第二十三中學;
【基金】：國家自然科學基金項目(31460241)
【分類號】：R256.12
【相似文獻】
相關期刊論文 前10條
1 夏紹軍;中醫(yī)藥與腫瘤的免疫調(diào)節(jié)概述[J];中醫(yī)藥臨床雜志;2004年04期
2 蔣保祥;影響中藥免疫調(diào)節(jié)因素的探討[J];江蘇中醫(yī);1999年05期
3 胡聰;“免疫調(diào)節(jié)中藥”述要[J];四川中醫(yī);1998年01期
4 郭紅云;劉秀玉;;中藥治療復發(fā)性阿弗他潰瘍免疫調(diào)節(jié)與療效觀察[J];中國民康醫(yī)學;2006年12期
5 馮立;張敏;;試論腎脾肺在妊娠免疫調(diào)節(jié)中的作用[J];浙江中醫(yī)學院學報;1993年06期
6 王甜甜;韓倩倩;吳芳;朱艷琴;;中藥對腫瘤患者的免疫調(diào)節(jié)[J];光明中醫(yī);2014年03期
7 周青山;賈新亭;田保利;;整體免疫調(diào)節(jié)防治艾滋病多發(fā)性感染[J];中國中醫(yī)藥信息雜志;2008年S1期
8 趙U，
本文編號：2523882
本文鏈接：http://www.wukwdryxk.cn/zhongyixuelunwen/2523882.html
最近更新
教材專著
